Translocation renal cell carcinoma: lack of negative impact due to lymph node spread.

Abstract:

BACKGROUND:Pediatric renal cell carcinoma (RCC) is clinically distinct from adult RCC. Characterization of the unique biological and clinical features of pediatric RCC are required. METHODS:A retrospective review and biological analysis of all RCC cases presenting to Cincinnati Children's Hospital Medical Center (CCHMC) in the last 30 years was undertaken. Cases were classified according to the recent World Heath Organization morphologic classification and according to TFE3/TFEB status. A literature review of pediatric TFE+ cases was performed. RESULTS:Eleven cases of RCC with clinical data were identified in our institutional review as follows: 6 clear cell, 2 papillary, 2 translocation, and 1 sarcomatoid. Upon reanalysis, 1 papillary and 1 sarcomatoid were confirmed, 1 case was "unclassified", and 8 of 11 (72.7%) had features consistent with translocation morphology. Of these 8, all demonstrated immunoreactivity for TFE3 (7 patients) or TFEB (1 patient) protein. In 3 cases, cytogenetics was available, each demonstrating confirmatory MiTF/TFE translocations. Seven of 8 TFE+ RCC patients presented with TNM Stage III/IV disease. Literature analysis confirmed a significant increase in advanced stage presentation in pediatric TFE+ RCC compared with TFE- RCC. Fourteen of fifteen (93.3%) patients with TFE+ stage III/IV RCC due to lymph node spread (N+ M(0)) remain disease free with a median and mean follow-up of 4.4 and 6.3 years, respectively (range, 0.3-15.5). CONCLUSIONS:Translocation morphology RCC is the predominant form of pediatric RCC, associated with an advanced stage at presentation. Patients with TFE+ N+ M(0) RCC maintain a favorable short-term prognosis after surgery alone. Young RCC patients should be screened for translocation morphology, and the screening information should be considered when debating adjuvant therapy.

journal_name

Cancer

journal_title

Cancer

authors

Geller JI,Argani P,Adeniran A,Hampton E,De Marzo A,Hicks J,Collins MH

doi

10.1002/cncr.23331

subject

Has Abstract

pub_date

2008-04-01 00:00:00

pages

1607-16

issue

7

eissn

0008-543X

issn

1097-0142

journal_volume

112

pub_type

杂志文章

相关文献

CANCER文献大全
  • Performance status and comorbidity in elderly cancer patients compared with young patients with neoplasia and elderly patients without neoplastic conditions.

    abstract:BACKGROUND:Elderly people constitute a heterogeneous group and are at an increased risk for the development of cancer. It is not clear whether comorbid conditions and functional status influence clinical decisions and the pattern of referral in elderly cancer patients. The current study investigated functional status m...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:

    authors: Repetto L,Venturino A,Vercelli M,Gianni W,Biancardi V,Casella C,Granetto C,Parodi S,Rosso R,Marigliano V

    更新日期:1998-02-15 00:00:00

  • p53 protein accumulation and p53 gene mutation in esophageal carcinoma. A molecular and immunohistochemical study with clinicopathologic correlations.

    abstract:BACKGROUND:p53 gene mutation and p53 protein accumulation are common in human cancer. However, their clinical significance is controversial and p53 accumulation may not correlate with gene mutation. The current study investigates the occurrence of p53 alterations in esophageal carcinoma, the correlation between the ana...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0142(19970201)79:3<425::aid-cnc

    authors: Coggi G,Bosari S,Roncalli M,Graziani D,Bossi P,Viale G,Buffa R,Ferrero S,Piazza M,Blandamura S,Segalin A,Bonavina L,Peracchia A

    更新日期:1997-02-01 00:00:00

  • Significance of plasma PTH-rp in patients with hypercalcemia of malignancy treated with bisphosphonate.

    abstract:BACKGROUND:Hypercalcemia of malignancy (HM) is one of the commonest metabolic complications associated with cancer. Plasma parathyroid hormone-related peptide (PTH-rp) is known to cause hypercalcemia in the vast majority of patients with HM. METHODS:Fifty-two patients with HM were treated with a single infusion of 60 ...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(19940415)73:8<2223::aid-cncr2820

    authors: Wimalawansa SJ

    更新日期:1994-04-15 00:00:00

  • Cytologic results of fine-needle aspiration biopsies of the central nervous system.

    abstract::The cytologic results of 34 fine-needle aspiration (FNA) biopsies of the central nervous system (CNS) are reported. There were 31 intraoperative biopsies performed at the time of craniotomy. All the cases were diagnosed using direct smear preparations stained with Papanicolaou and Diff-Quik (Harleco, NJ) stains. The s...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19860901)58:5<1117::aid-cncr2820

    authors: Silverman JF,Timmons RL,Leonard JR 3rd,Hardy IM,Harris LS,O'Brien K,Norris HT

    更新日期:1986-09-01 00:00:00

  • Anaplastic astrocytoma of the adult cerebrum. Prognostic value of histologic features.

    abstract::Initial biopsy and resection specimens from 78 cerebral astrocytomas with anaplastic foci occurring in adults were examined for the presence of five specific histologic features traditionally considered indicative of anaplasia. Anaplastic astrocytomas with foci of tumor necrosis had been classified as glioblastoma mul...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19850301)55:5<928::aid-cncr28205

    authors: Fulling KH,Garcia DM

    更新日期:1985-03-01 00:00:00

  • Case-linked analysis of clinical trial enrollment among adolescents and young adults at a National Cancer Institute-designated comprehensive cancer center.

    abstract:BACKGROUND:Poor accrual to cancer clinical trials may contribute to the lower improvement in survival observed for adolescents and young adults (AYAs) (those aged 15-39 years) with cancer. This has been difficult to quantify without reliable mechanisms to link incident cases with study enrollments. Using unique resourc...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.29669

    authors: Collins CL,Malvar J,Hamilton AS,Deapen DM,Freyer DR

    更新日期:2015-12-15 00:00:00

  • Cyclin E expression is correlated with tumor progression and predicts a poor prognosis in patients with ovarian carcinoma.

    abstract:BACKGROUND:Cyclins, cyclin dependent kinases (cdks), and their inhibitors act in combination to regulate progression through the cell cycle and often are dysregulated in carcinoma. The authors hypothesized that cyclin E plays an important role in ovarian carcinogenesis and that its overexpression may be an indicator of...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.21767

    authors: Rosen DG,Yang G,Deavers MT,Malpica A,Kavanagh JJ,Mills GB,Liu J

    更新日期:2006-05-01 00:00:00

  • Parathyroid hormone-related protein is an independent prognostic factor for renal cell carcinoma.

    abstract:BACKGROUND:Parathyroid hormone-related protein (PTHrP) has been shown to be the principal cause of humoral hypercalcemia associated with renal cell carcinoma (RCC). Recent studies have demonstrated that the amino-terminal region of PTHrP has growth factor-like activities, suggesting it may play a role in the developmen...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0142(19990915)86:6<1028::aid-cn

    authors: Iwamura M,Wu W,Muramoto M,Ohori M,Egawa S,Uchida T,Baba S

    更新日期:1999-09-15 00:00:00

  • Adjuvant chemotherapy for advanced head and neck squamous carcinoma. Final report of the Head and Neck Contracts Program.

    abstract::To determine the efficacy of adjuvant chemotherapy in patients with advanced head and neck squamous carcinoma, the National Cancer Institute initiated a multi-institutional, prospective randomized trial termed the Head and Neck Contracts Program. Between 1978 and 1982, 462 patients with resectable Stage III or IV canc...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1002/1097-0142(19870801)60:3<301::aid-cncr28206

    authors:

    更新日期:1987-08-01 00:00:00

  • Parathyroid hormone-related protein expression in gynecic squamous carcinoma cells.

    abstract:BACKGROUND:The regulation of parathyroid hormone-related protein (PTH-rP) mRNA levels and immunoreactive (ir)PTH-rP formation by peptide growth factors, particularly transforming growth factor-beta (TGF-beta) and epidermal growth factor (EGF), in squamous cell carcinomas of gynecologic origin is largely unknown. METHO...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19940301)73:5<1515::aid-cncr2820

    authors: Tait DL,MacDonald PC,Casey ML

    更新日期:1994-03-01 00:00:00

  • Ovarian dysplasia: nuclear texture analysis.

    abstract:BACKGROUND:Ovarian dysplasia has been defined by histologic and morphometric studies focusing on architectural and nuclear profile changes. A new technique is used to enhance the accuracy of this diagnosis by a quantitative evaluation of the nuclear texture that represents the nuclear chromatin pattern on which convent...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19931201)72:11<3253::aid-cncr282

    authors: Deligdisch L,Miranda C,Barba J,Gil J

    更新日期:1993-12-01 00:00:00

  • Giant cell tumor ("osteoclastoma") of the pancreas: a tumor of epithelial origin.

    abstract::Carcinomas of the pancreas with giant cells are not rare, but those containing osteoclast-like tumor cells are quite unusual. This report documents a pancreatic neoplasm comprising both easily recognizable well-differentiated adenocarcinoma and osteoclast-like tumor. The literature on the "osteoclastoma" of the pancre...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19811101)48:9<2022::aid-cncr2820

    authors: Trepeta RW,Mathur B,Lagin S,LiVolsi VA

    更新日期:1981-11-01 00:00:00

  • Receptor activator of NF-kappaB ligand, macrophage inflammatory protein-1alpha, and the proteasome: novel therapeutic targets in myeloma.

    abstract:BACKGROUND:The bone destruction in myeloma patients is largely responsible for the clinical features of the disease. However, only recently has attention focused on identifying and developing drugs targeted specifically at the osteolysis. Receptor activator of NF-kappaB ligand (RANKL), macrophage inflammatory protein (...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.11133

    authors: Oyajobi BO,Mundy GR

    更新日期:2003-02-01 00:00:00

  • Multimodality therapy for patients with clinical Stage I and II malignant mixed Müllerian tumors of the uterus.

    abstract:BACKGROUND:The role of adjuvant therapy in the management of patients with malignant mixed Müllerian tumors (MMMT) of the uterus has not been defined. The outcome of planned multimodality therapy for patients with apparent early stage disease was assessed. METHODS:A pilot study was performed on 38 patients with clinic...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:

    authors: Manolitsas TP,Wain GV,Williams KE,Freidlander M,Hacker NF

    更新日期:2001-04-15 00:00:00

  • Evaluation of ovarian findings in asymptomatic postmenopausal women with color Doppler ultrasound.

    abstract:BACKGROUND:To evaluate the prevalence and significance of abnormal ovarian findings in asymptomatic postmenopausal women, screening for ovarian cancer with color Doppler ultrasound was performed. METHODS:One thousand three hundred sixty-four asymptomatic women aged 56-61 years (mean, 59 years) were examined by color D...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(19951001)76:7<1214::aid-cncr2820

    authors: Vuento MH,Pirhonen JP,Mäkinen JI,Laippala PJ,Grönroos M,Salmi TA

    更新日期:1995-10-01 00:00:00

  • The benefit of induction chemotherapy in patients age > or = 75 years.

    abstract:BACKGROUND:Patients age > or = 75 years with acute myeloid leukemia (AML) generally are offered palliative treatments instead of induction chemotherapy. The authors conducted a retrospective study comparing the outcomes among these elderly patients with the outcomes among younger patients to assess the impact of intens...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.20353

    authors: Vey N,Coso D,Bardou VJ,Stoppa AM,Braud AC,Bouabdallah R,Sainty D,Mozziconacci MJ,Lafage M,Damaj G,Blaise D,Gastaut JA,Maraninchi D

    更新日期:2004-07-15 00:00:00

  • Axillary lymph nodes and breast cancer: a review.

    abstract:BACKGROUND:The value of surgical staging and treatment of the axillary lymph nodes with either surgery or radiotherapy in the initial management of patients with Stage I or II invasive breast cancer is controversial. METHODS:A review of retrospective and prospective clinical studies was performed to assess the risks o...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/1097-0142(19951101)76:9<1491::aid-cncr2820

    authors: Recht A,Houlihan MJ

    更新日期:1995-11-01 00:00:00

  • Central venous device-related infection and thrombosis in patients treated with moderate dose continuous-infusion interleukin-2.

    abstract:BACKGROUND:This study was performed to determine the incidence of central venous device-related blood stream infection and thrombosis in patients treated with moderate dose continuous-infusion interleukin-2 (IL-2). METHODS:The records of 160 consecutive patients treated at the University of Wisconsin Hospital and Clin...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:

    authors: Eastman ME,Khorsand M,Maki DG,Williams EC,Kim K,Sondel PM,Schiller JH,Albertini MR

    更新日期:2001-02-15 00:00:00

  • Primary retroperitoneal seminoma.

    abstract::In a retrospective review (1950-1975) of the Mayo Clinic experience with seminomas (483 cases), twelve patients (2.5%) were found to have a retroperitoneal seminoma without evidence of testicular involvement. The mean age was 47 years (range, 31-67). Eleven patients were treated by radiation alone, with doses ranging ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19820501)49:9<1934::aid-cncr2820

    authors: Buskirk SJ,Evans RG,Farrow GM,Earle JD

    更新日期:1982-05-01 00:00:00

  • Chondrosarcoma with additional mesenchymal component (dedifferentiated chondrosarcoma). II. An immunohistochemical and electron microscopic study.

    abstract::Light microscopic, immunocytochemical and ultrastructural studies were performed on chondrosarcomas which contained a second, noncartilagenous mesenchymal component. Attention was focused on the nonchondroid portion of each tumor in an attempt to elucidate the histogenesis of this mixed variant of chondrosarcoma. The ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19860715)58:2<287::aid-cncr28205

    authors: Têtu B,Ordóñez NG,Ayala AG,Mackay B

    更新日期:1986-07-15 00:00:00

  • Implications of false-positive results for future cancer screenings.

    abstract:BACKGROUND:False-positive cancer screening results may affect a patient's willingness to obtain future screening. METHODS:The authors conducted logistic regression analysis of 450,484 person-years of electronic medical records (2006-2015) in 92,405 individuals aged 50 to 75 years. Exposures were false-positive breast,...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.31271

    authors: Taksler GB,Keating NL,Rothberg MB

    更新日期:2018-06-01 00:00:00

  • Prognostic factors in telecobalt therapy for early supraglottic carcinoma.

    abstract:BACKGROUND:The local control rates of T1 and T2 supraglottic carcinoma treated with radiation alone were reported as 71% to 92% and 59% to 83%, respectively. The factors that affect the local control rate for early supraglottic carcinoma were investigated. METHODS:From 1967 through 1985, 100 cases with early supraglot...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19930701)72:1<57::aid-cncr282072

    authors: Inoue T,Matayoshi Y,Inoue T,Ikeda H,Teshima T,Murayama S

    更新日期:1993-07-01 00:00:00

  • Metronomic therapy with cyclophosphamide and dexamethasone for prostate carcinoma.

    abstract:BACKGROUND:The current study was designed to evaluate the efficacy and toxicity of the continuous oral administration of a combination of cyclophosphamide (50 mg/day given in the morning) and dexamethasone (1 mg/day given in the evening) in patients with prostate specific antigen (PSA) progression despite single or mul...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.11713

    authors: Glode LM,Barqawi A,Crighton F,Crawford ED,Kerbel R

    更新日期:2003-10-15 00:00:00

  • How well do medical oncologists' perceptions reflect their patients' reported physical and psychosocial problems? Data from a survey of five oncologists.

    abstract:BACKGROUND:Modern cancer treatments can cure or prolong patients' lives. However, the associated physical and psychosocial problems can detrimentally affect patients' compliance with treatment and, ultimately, their outcomes. Therefore, oncologists need to recognize the problems experienced by their patients and, when ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:

    authors: Newell S,Sanson-Fisher RW,Girgis A,Bonaventura A

    更新日期:1998-10-15 00:00:00

  • Restoring platinum sensitivity in recurrent ovarian cancer by extending the platinum-free interval: Myth or reality?

    abstract::The platinum-free interval is the most important predictive factor of a response to subsequent lines of chemotherapy and the most important prognostic factor for progression-free and overall survival in patients with recurrent epithelial ovarian cancer. A nonplatinum regimen is generally considered the most appropriat...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/cncr.30830

    authors: Tomao F,D'Incalci M,Biagioli E,Peccatori FA,Colombo N

    更新日期:2017-09-15 00:00:00

  • High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors.

    abstract:BACKGROUND:Desmoid tumors are mesenchymal nonmetastasizing neoplasms. Although rare in the general population, they are a common extracolonic manifestation of familial adenomatous polyposis (FAP). Because of high tumor recurrence rates, surgery has been less than satisfactory in the treatment of desmoid tumors. In the ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.11937

    authors: Hansmann A,Adolph C,Vogel T,Unger A,Moeslein G

    更新日期:2004-02-01 00:00:00

  • Improved survival in women with BRCA-associated ovarian carcinoma.

    abstract:BACKGROUND:The objective of this study was to determine the clinical characteristics, treatment response, and frequency of p53 overexpression in Ashkenazi Jewish women with hereditary ovarian carcinoma. METHODS:Seventy-one Jewish women with epithelial ovarian carcinoma (EOC) were tested for the three BRCA founder muta...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.11310

    authors: Cass I,Baldwin RL,Varkey T,Moslehi R,Narod SA,Karlan BY

    更新日期:2003-05-01 00:00:00

  • Indicators of survival duration in ovarian cancer and implications for aggressiveness of care.

    abstract:BACKGROUND:Ovarian cancer patients frequently receive chemotherapy near the end of life. The purpose of the current study was to develop indicators that characterize those ovarian cancer patients who have a short life span. METHODS:The medical charts of deceased epithelial ovarian cancer patients were retrospectively ...

    journal_title:Cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1002/cncr.23391

    authors: von Gruenigen V,Daly B,Gibbons H,Hutchins J,Green A

    更新日期:2008-05-15 00:00:00

  • Phase I-II trial of percutaneous intra-arterial cis-diamminedichloro platinum (II) for regionally confined malignancy.

    abstract::Forty-nine patients with regionally confined recurrent malignancy were treated with intra-arterial cis-diamminedichloro platinum II in a Phase I-II trial. A safe starting dose of 120 mg/m2 was established. An overall response rate of 45% was noted with significant responses observed among patients with melanoma, sarco...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19800315)45:6<1278::aid-cncr2820

    authors: Calvo DB 3rd,Patt YZ,Wallace S,Chuang VP,Benjamin RS,Pritchard JD,Hersh EM,Bodey GP Sr,Mavligit GM

    更新日期:1980-03-15 00:00:00

  • P-glycoprotein expression in canine lymphoma: a relevant, intermediate model of multidrug resistance.

    abstract:BACKGROUND:Despite extensive investigation, the role of MDR of human cancer remains unclear. Canine lymphoma is a spontaneously arising correlate of human non-Hodgkin's lymphoma that may complement other in vivo models for investigation of issues related to MDR. METHODS:Immunoreactivity of primary antibodies to the hu...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(SICI)1097-0142(19960501)77:9<1892::AID-CN

    authors: Lee JJ,Hughes CS,Fine RL,Page RL

    更新日期:1996-05-01 00:00:00